Biomx Inc logo

PHGE - Biomx Inc News Story

$6.48 -0.3  -3.9%

Last Trade - 4:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £257.1m
Enterprise Value £216.2m
Revenue £n/a
Position in Universe 3941st / 6851

BRIEF-BiomX Enters Collaboration With Boehringer Ingelheim

Wed 2nd September, 2020 11:32am
Sept 2 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX ENTERS COLLABORATION WITH BOEHRINGER INGELHEIM WITH
THE
GOAL OF DISCOVERING MICROBIOME-BASED BIOMARKERS FOR INFLAMMATORY
BOWEL DISEASE
    * BIOMX ENTERS COLLABORATION WITH BOEHRINGER INGELHEIM WITH
GOAL
OF DISCOVERING MICROBIOME-BASED BIOMARKERS FOR INFLAMMATORY
BOWEL DISEASE
    * BIOMX - TO GENERATE METAGENOMIC DATA OF GUT MICROBIOME
SAMPLES
OBTAINED FROM IBD PATIENTS WITH AIM OF IDENTIFYING BIOMARKERS
USING XMARKER PLATFORM
    * BIOMX INC - CONTINUES TO ADVANCE WHOLLY-OWNED PHAGE
THERAPY
CANDIDATE BX002 FOR TREATMENT OF IBD WITH A PHASE 1A STUDY
EXPECTED TO BEGIN IN Q3 OF 2020
    * BIOMX INC - TERMS INCLUDE AN OPTION FOR BOEHRINGER
INGELHEIM TO
NEGOTIATE AN EXCLUSIVE RIGHT TO BIOMARKERS DISCOVERED UTILIZING
XMARKER PLATFORM

Source text for Eikon:  ID:nBw7m9PZVa 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.